Its not about eating less
NativePath Collagen is not a drug and has not undergone the FDA new drug application or pre-market approval process required for pharmaceutical products
A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models
That would help patients with treatment-resistant insomnia, patients in structured opioid withdrawal programs, and potentially patients with narcolepsy who have not responded to standard medications
The future outlook While still early, GLP-1 medications may represent one of the largest long-term disruptors to the global food industry, likely to transform the relationship consumers have with food, shifting from quantity and impulse toward more intentional, higher-value eating occasions
10.1016/s0168-9525(03)00115-x 30 ChandraD.JahangirA.CornelisF.RombautsK.MeheusL.JorcykC